Continue reading → mGluR5 as a Point of Convergence for Models of OCD and Autism Posted by Dr Natalie Matosin in Publication Archive Continue reading →
Continue reading → Molecular evidence of synaptic pathology in the CA1 region in schizophrenia Posted by Dr Natalie Matosin in Publication Archive Continue reading →
Continue reading → Shifting towards a model of mGluR5 dysregulation in schizophrenia Posted by Dr Natalie Matosin in Publication Archive Continue reading →
Continue reading → Sex-specific effects of FRMPD4 in schizophrenia Posted by Dr Natalie Matosin in Publication Archive Continue reading →
Continue reading → mGluR5 + its trafficking molecules are increased in the hippocampus in schizophrenia Posted by Dr Natalie Matosin in Publication Archive Continue reading →
Continue reading → Altered mGluR5 and its endogenous regulators Norbin, Tamalin and Preso1 in schizophrenia Posted by Dr Natalie Matosin in Publication Archive Continue reading →
Continue reading → Positives in negative results: when finding ‘nothing’ means something Posted by Dr Natalie Matosin in For the Public, Publication Archive Continue reading →
Continue reading → mGluR2/3 and mGluR5 binding in the anterior cingulate cortex in psychiatric disorders Posted by Dr Natalie Matosin in Publication Archive Continue reading →
Continue reading → The disconnect between scientific worth and scientific culture Posted by Dr Natalie Matosin in For Scientists, For the Public, Publication Archive Continue reading →
Continue reading → Rethinking mGluR5 in psychiatric disorders: implications for future therapeutics Posted by Dr Natalie Matosin in Publication Archive Continue reading →
Continue reading → mGluR5 in the pathology and treatment of schizophrenia Posted by Dr Natalie Matosin in Publication Archive Continue reading →
